A personal approach to detecting cancer

New technologies from Personalis can detect cancer recurrence earlier

It’s the sobering—and all-too regular—experience for any cancer survivor: waiting for their doctor to reveal the test results that show if the disease has returned. “These are the moments where everybody in the family takes a deep breath,” says Chris Hall, CEO of Personalis, a biotechnology company based in Fremont, California.